Withdrawal of hospital outpatient treatments in severe diseases due to unacceptable toxicity: A retrospective study from the register of patients and treatments.

Saved in:
Bibliographic Details
Title: Withdrawal of hospital outpatient treatments in severe diseases due to unacceptable toxicity: A retrospective study from the register of patients and treatments.
Authors: Agustí A; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Aguilera C; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Bosch M; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Danés I; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Pérez E; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain., Vendrell L; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain., Aller MB; Department of Information Systems and Decision Support, Vall d'Hebron University Hospital, Barcelona, Spain.; Health Services Research Group, Institut de Recerca Vall d'Hebron, Barcelona, Spain., Boixareu N; Department of Information Systems and Decision Support, Vall d'Hebron University Hospital, Barcelona, Spain.; Health Services Research Group, Institut de Recerca Vall d'Hebron, Barcelona, Spain., García-Doladé N; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain., Diogène E; Clinical Pharmacology Service, Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Catalan Institute of Pharmacology Foundation, Vall Hebron University Hospital, Barcelona, Spain.; Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jun; Vol. 87 (6), pp. 2549-2557. Date of Electronic Publication: 2020 Dec 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2125
DOI:10.1111/bcp.14665